Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Senior Physician | St. Franziskus-Hospital | Germany

Dr. Claudia Lommatzsch is a distinguished clinician-scientist in ophthalmology, recognized for her significant contributions to glaucoma diagnostics, ocular imaging, and translational vision research. She received her medical education from a leading German medical university and later achieved advanced academic qualification through habilitation, reflecting her expertise in independent research and university-level teaching. Professionally, Dr. Claudia Lommatzsch has built a strong career as a senior physician and researcher within a major ophthalmology department, where she seamlessly integrates clinical responsibilities with innovative research activities. Her professional experience spans patient-centered glaucoma care, advanced imaging diagnostics, and interdisciplinary research collaborations that connect clinical ophthalmology with laboratory-based biomarker analysis. Her primary research interests include glaucoma pathophysiology, optical coherence tomography, OCT angiography, vascular and molecular biomarkers, pediatric ocular imaging, and disease progression assessment, with a particular emphasis on improving early diagnosis and personalized treatment strategies. In the middle of her academic career trajectory, she has authored 28 documents, accumulated 316 citations, and achieved an h-index of 8, demonstrating measurable scientific impact and consistent research productivity within indexed international journals.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations316

i10index28

h-index8

๐ŸŸฆ Citationsย  ย  ๐ŸŸฅ Documentsย  ย  ย  ๐ŸŸฉ h-index

View scopus Profile
ย ย  ย ย  ย ย View ORCID Profile

Featured Publications

ET-1, MMPs, ZAG, and APN Link Reduced Ocular Perfusion to Glaucoma

โ€“ Biomolecules, Open Access

Assessment of Chronic Degenerative Eye Disease Progression

โ€“ Editorial, Open Access

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Floridaโ€™s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profileย 

๐ŸŽ“ Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolutionโ€”making him a uniquely qualified academic leader and international research collaborator.

๐Ÿ’ผ Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

๐Ÿ”ฌ Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathakโ€™s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathakโ€™s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

๐Ÿ† Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republicโ€”recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

๐Ÿ Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

๐Ÿ“š Publications of Jibamitra Ganguly

ย  ย  ย  ย  ย  1. Title: CAR T cells in solid tumors: challenges and opportunities
ย  ย  ย  ย  ย  ย  ย  Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
ย  ย  ย  ย  ย  ย  ย  Year: 2021
ย  ย  ย  ย  ย  ย  ย  Citations: 611

ย  ย  ย  ย  ย  2. Title: Nanoparticulate drug-delivery systems: an overview
ย  ย  ย  ย  ย  ย  ย  Authors: D. Thassu, Y. Pathak, M. Deleers
ย  ย  ย  ย  ย  ย  ย  Year: 2007
ย  ย  ย  ย  ย  ย  ย  Citations: 349

ย  ย  ย  ย  ย  3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
ย  ย  ย  ย  ย  ย  ย  Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
ย  ย  ย  ย  ย  ย  ย  Year: 2021
ย  ย  ย  ย  ย  ย  ย  Citations: 310

ย  ย  ย  ย  ย 4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
ย  ย  ย  ย  ย  ย  ย Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
ย  ย  ย  ย  ย  ย  ย Year: 2021
ย  ย  ย  ย  ย  ย  ย Citations: 279

ย  ย  ย  ย  ย 5. Title: Drug delivery nanoparticles formulation and characterization
ย  ย  ย  ย  ย  ย  ย Authors: Y. Pathak, D. Thassu
ย  ย  ย  ย  ย  ย  ย Year: 2009
ย  ย  ย  ย  ย  ย  ย Citations: 224

ย  ย  ย  ย  ย  6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
ย  ย  ย  ย  ย  ย  ย  Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
ย  ย  ย  ย  ย  ย  ย Year: 2021
ย  ย  ย  ย  ย  ย  ย Citations: 195

ย  ย  ย  ย  ย 7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
ย  ย  ย  ย  ย  ย  ย Authors: A. Barkai, Y.V. Pathak, S. Benita
ย  ย  ย  ย  ย  ย  ย Year: 1990
ย  ย  ย  ย  ย  ย  ย Citations: 169

ย  ย  ย  ย  ย 8. Title: Ocular drug delivery: impact of in vitro cell culture models
ย  ย  ย  ย  ย  ย  ย Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
ย  ย  ย  ย  ย  ย  ย Year: 2016
ย  ย  ย  ย  ย  ย  ย Citations: 165

ย  ย  ย  ย  ย 9. Title: Surface modification of nanoparticles for targeted drug delivery
ย  ย  ย  ย  ย  ย  ย Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
ย  ย  ย  ย  ย  ย  ย Year: 2019
ย  ย  ย  ย  ย  ย  ย Citations: 139

ย  ย  ย  ย 10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
ย  ย  ย  ย  ย  ย  ย Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
ย  ย  ย  ย  ย  ย  ย Year: 2009
ย  ย  ย  ย  ย  ย  ย Citations: 112

 

 

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Masterโ€™s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Childrenโ€™s Hospital in Tunis, Tunisia (1993โ€“2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissiโ€™s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including โ€œAl Kaissi syndromeโ€ (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome โ€“ OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser โ€“ OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • โ€œProgressive Collapse of the Thoracic Cageโ€ โ€“ American Journal of Medicine, 2017.

  • โ€œNovel Conception of Wormian Bonesโ€ โ€“ Diagnostics Journal, 2023.

  • โ€œSkeletal Pathology in Arctic Wildlifeโ€ โ€“ Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • โ€œMeticulous and Early Understanding of Cranial Defects Can Save Livesโ€ โ€“ Children, 2023.

  • โ€œCraniofacial Malformations in Syndromic Entitiesโ€ โ€“ Diagnostics, 2022.

  • โ€œArthrogryposis and Escobar Syndromeโ€ โ€“ Minerva Pediatrics, 2024.

  • โ€œNon-lethal ZMPSTE24 Mutation in Progeriaโ€ โ€“ Clinical Genetics, 2023.

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Prof Lina Vieira, ESTeSL/IPL, Portugal

Prof. Lina Vieira is a distinguished biomedical researcher and educator with a PhD in Biomedical Engineering and Biophysics from the University of Lisbon ๐ŸŽ“, awarded with Distinction and Honors ๐Ÿ…. Her work primarily advances nuclear medicine, with a special focus on myocardial perfusion scintigraphy and SPECT imaging ๐Ÿง โค๏ธ. She holds a professorial position at the Lisbon School of Health Technology, actively contributing to both teaching and scientific innovation ๐Ÿ“š๐Ÿ”ฌ. Prof. Vieira has led several EU-funded projects, including PIANOFORTE, focusing on safe, optimized radiology for vulnerable populations ๐Ÿคฐ๐Ÿ“ก. Her research blends technology, biophysics, and human-centered approaches like anxiety reduction and music therapy in imaging ๐Ÿง˜โ€โ™€๏ธ๐ŸŽต. An award-winning author and supervisor, she has trained numerous graduate students and remains a leading voice in radiological safety and optimization โš›๏ธ. Her scientific rigor, innovation, and societal impact make her an ideal candidate for the Research Hypothesis Excellence Award ๐Ÿ†๐Ÿ”.

Publication Profile

Orcid

Education

Prof. Lina Vieira earned her PhD in Biomedical Engineering and Biophysics from the University of Lisbon in 2011 with Distinction and Honors ๐ŸŽ“๐ŸŒŸ. Her thesis focused on optimizing myocardial perfusion studies using ECG-gated nuclear medicine imaging โค๏ธ๐Ÿง . She also holds a Postgraduate Degree in Medical Physics and Biomedical Engineering (2005) and a Bachelor’s in Nuclear Medicine (2000) from the Lisbon School of Health Technology โš›๏ธ๐Ÿ“˜. As part of her academic growth, she qualified through rigorous public examinations to become a Coordinating Professor in Nuclear Medicine within the Radiation Sciences and Biosignal Technologies Department at ESTeSL ๐Ÿ‘ฉโ€๐Ÿซ๐Ÿงช. Her scholarly training is grounded in biophysics, imaging technology, and healthcare applications, forming a strong foundation for her future academic, research, and leadership achievements ๐Ÿ”ฌ๐Ÿ’ก.

Experience

Prof. Vieira serves as a Coordinating Professor at the Lisbon School of Health Technology, leading Nuclear Medicine teaching and research initiatives ๐Ÿ‘ฉโ€๐Ÿซ๐Ÿง . She has been an integrated member of the Health & Technology Research Center since 2019, previously with the Institute of Biophysics and Biomedical Engineering at the University of Lisbon ๐Ÿงฌ๐Ÿ“Š. Her work spans across modeling, signal processing, and human-centered diagnostic imaging, including participation in CIMOSM and GI-MOSM research centers ๐Ÿง โš™๏ธ. Notably, she coordinates the EU-funded PIANOFORTE project on safe radiology for pregnant patients ๐Ÿคฐ๐Ÿ“ก, and leads innovative research on anxiety and music’s impact on image quality ๐ŸŽต๐Ÿ˜Œ. Prof. Vieira is a mentor to many MSc students and has supervised several dissertations on SPECT imaging, Parkinsonโ€™s diagnostics, and PET education ๐Ÿ“š๐Ÿ“. Her cross-disciplinary expertise makes her a leader in merging clinical practice with scientific excellence ๐Ÿฅ๐Ÿ”.

Awards and Honors

Prof. Vieira has received multiple prestigious awards honoring her innovative research in nuclear medicine and imaging technology ๐Ÿ…๐Ÿ“ก. She earned the Best Scientific Article Award from Saรบde & Tecnologia in 2018, 2017, and 2015 for studies on technologist exposure, myocardial perfusion, and PET/CT in melanoma surveillance ๐ŸŽ–๏ธ๐Ÿ“˜. Her paper, โ€œValue of a Lower Limb Immobilization Device for Optimization of SPECT/CT Image Fusion,โ€ was named one of the Top 3 Papers by JNMT in 2015 and recognized at the 2016 Annual SNMMI Congress in San Diego ๐Ÿ‡บ๐Ÿ‡ธโœจ. These accolades reflect her commitment to high-impact, hypothesis-driven research that enhances clinical outcomes and patient safety ๐Ÿง โค๏ธ. With consistent recognition over the years, Prof. Vieira continues to lead innovations in nuclear medicine, both theoretically and practically ๐Ÿ”ฌ๐Ÿ“ˆ.

Research Focus

Prof. Vieira’s research centers on optimizing nuclear medicine imaging, particularly myocardial perfusion scintigraphy (MPS), SPECT acquisition techniques, and patient-centered innovations in diagnostic imaging โค๏ธ๐Ÿ“ธ. She investigates the impact of psychophysiological variables, such as anxiety, on image quality and explores non-pharmacological interventions like music therapy to improve patient outcomes ๐ŸŽถ๐Ÿง˜โ€โ™‚๏ธ. A strong advocate for radiological safety, she spearheads projects like PIANOFORTE, which targets personalized radiology for pregnant patients ๐Ÿคฐโš›๏ธ. She also delves into educational methodologies, evaluating the effect of videos and social media in communicating ionizing radiation risks effectively ๐Ÿ“ฒ๐Ÿง . Her interdisciplinary focus combines engineering, patient psychology, radiological science, and public communicationโ€”making her work vital for improving both technical precision and patient experience in medical imaging ๐Ÿ’ก๐Ÿฉบ. Her hypothesis-driven approach is rooted in measurable impacts, clinical relevance, and ethical responsibility ๐Ÿ”๐Ÿ“.

Publication Top Notes

  • ๐Ÿ“„ Myocardial Perfusion Scintigraphy: Impact of Anxiety on Image Quality (JPM, 2025 โ€“ submitted)

  • ๐Ÿ“„ Potential Benefits of Social Media in Educating Healthcare Professionals and Students on Medical Imaging with Ionizing Radiation (Radiography Journal, 2025)

  • ๐Ÿ“„ Effects of a Music-Based Intervention on Psychophysiological Outcomes of Patients Undergoing Imaging Procedures: A Systematic Review (Radiography Journal, 2024)

  • ๐Ÿ“„ Effectiveness of Educational Videos on Patientโ€™s Preparation for Diagnostic Procedures: Systematic Review and Meta-Analysis (Preventive Medicine Reports, 2022)

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clรญnico San Carlos, Spain

Mr. Bruno Songel Sanchis ๐ŸŽป๐Ÿ‘“ is a versatile professional with dual expertise in music and vision sciences. Holding a Masterโ€™s in Optometry and Vision Sciences from the Complutense University of Madrid ๐ŸŽ“, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clรญnico San Carlos and Fundaciรณn Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology ๐Ÿค–๐Ÿง . Beyond clinics, Brunoโ€™s passion for community service is evident through his impactful volunteer roles and outreach projects ๐Ÿซถ. A talented cellist ๐ŸŽถ and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth ๐Ÿ“„๐Ÿ“Š. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award ๐Ÿฅ‡๐Ÿงฌ.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background ๐ŸŽ“โœจ. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia ๐ŸŽป, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San Josรฉ de Calasanz High School ๐Ÿงช๐Ÿ“˜. Brunoโ€™s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry ๐Ÿ‘๏ธ๐Ÿ“. Committed to advancing vision care, he continued with a Masterโ€™s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid ๐Ÿ‘“๐Ÿ”ฌ. Heโ€™s currently engaged in Project Efficiency Boost (2025โ€“present), enhancing clinical productivity through AI and innovation ๐Ÿš€๐Ÿค–. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research ๐Ÿง ๐Ÿ“š.

Experience

Bruno has extensive hands-on experience in both clinical and research settings ๐Ÿฅ๐Ÿ”ฌ. He served as a Clinical Optometrist at Hospital Clรญnico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts ๐Ÿ‘๏ธ๐Ÿ’‰. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the โ€˜LYDIA projectโ€™ developing AI diagnostic tools ๐Ÿค–๐Ÿ“Š. His role as a Product Specialist marked a major milestoneโ€”implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital ๐Ÿฅโœจ. Earlier, he worked at ร“ptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care ๐Ÿ› ๏ธ๐Ÿ›๏ธ. Bruno also holds a current role at Fundaciรณn Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus ๐Ÿ‘“๐Ÿซถ.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence ๐Ÿ†๐Ÿ“š. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement ๐ŸŽจ๐Ÿ’ก. At the UVemprรฉn Startup โ€“ Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare ๐Ÿ”ฌ๐Ÿš€. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities ๐ŸŽถ๐Ÿ…. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership ๐Ÿ“˜๐Ÿ‘. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication ๐Ÿ—ฃ๏ธ๐Ÿ“Š. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level ๐ŸŒ๐Ÿ‘๏ธ.

Research Focus

Bruno Songel Sanchisโ€™s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology ๐Ÿง ๐Ÿ‘๏ธ๐Ÿค–. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems ๐Ÿงฌ๐Ÿ“ˆ. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care ๐Ÿ“„๐Ÿฉบ. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally ๐ŸŒโœจ. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements ๐Ÿฉป๐Ÿ“Š.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

 

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Assoc. Prof. Dr Lucia Ciranna, Universitร  di Catania, Italy

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her groundbreaking research on the serotonin brain system, Fragile X Syndrome, and neurodevelopmental disorders. With a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg (1995) and a Pharmacy degree from the University of Catania (1989), she has significantly advanced understanding of neurological diseases. As an Associate Professor of Physiology at the University of Catania since 2006, she has led innovative studies on neurodevelopment and therapeutic interventions. Her extensive research contributions, spanning over three decades, have earned her prestigious qualifications in France and Italy. Dr. Cirannaโ€™s work has been instrumental in exploring the therapeutic potential of serotonin modulation, glial interactions, and receptor mechanisms in neurological disorders. Her prolific publication record and dedication to advancing neuroscience make her a deserving recipient of the Women Researcher Award. ๐Ÿง ๐Ÿ“š๐Ÿ…

Publication Profile

Scopus

Educationย 

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist with a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg, France (1995) ๐Ÿง , where she focused on serotonin neurotransmission and neurodevelopment. She earned her Pharmacy degree from the University of Catania (1989) ๐Ÿ’Š, specializing in neuropharmacology and brain physiology. Her postdoctoral research at the University of Catania (1995-1998) ๐Ÿ”ฌ explored serotoninโ€™s role in synaptic plasticity and cognition. Further advancing her expertise, she trained in molecular neuroscience and pharmacology (1998-2000) ๐ŸŽ“. Dedicated to lifelong learning, she actively engages in international neuroscience workshops and research collaborations ๐Ÿ“–.

Experience

Assoc. Prof. Dr. Lucia Ciranna is a distinguished physiologist at the University of Catania (2006-Present) ๐Ÿซ, leading groundbreaking research on serotoninโ€™s role in neurological disorders and innovative therapeutic strategies. Previously, she was a researcher at the same institution (1994-2006) ๐Ÿ”ฌ, investigating neurophysiology in cognitive impairments and receptor signaling. She earned her Ph.D. from Louis Pasteur University of Strasbourg (1990-1994) ๐ŸŽ“, focusing on neurodevelopmental mechanisms and serotonin modulation in brain function. Earlier, she contributed to neuropharmacology research at the University of Catania (1989-1990) ๐Ÿงฌ. As a scientific collaborator with international neuroscience labs ๐ŸŒ, she continues exploring cutting-edge advancements in the field.

Awards and Honors

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her contributions to neurophysiology ๐Ÿง . She achieved the Qualification to the function of Professeur des Universitรฉ in France (2012) ๐Ÿ‡ซ๐Ÿ‡ท and later became a Professore Ordinario (Full Professor of Physiology) in 2018 ๐ŸŽ“. Her research has been supported by prestigious international neuroscience grants ๐Ÿ’ฐ, driving innovation in the field. A sought-after speaker, she has delivered distinguished lectures at major neurophysiology conferences worldwide ๐ŸŽค. Dr. Cirannaโ€™s groundbreaking work on Fragile X Syndrome has earned her accolades for excellence in neurodevelopmental research ๐Ÿ….

Presentation

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist specializing in serotonin receptor modulation and its implications for neurodevelopmental disorders ๐Ÿง ๐Ÿ”ฌ. She has delivered numerous invited seminars and conference presentations worldwide, focusing on the role of 5-HT7 serotonin receptors in synaptic plasticity, cognition, and behavior. Her research explores therapeutic strategies for Fragile X Syndrome and Autism Spectrum Disorders, with key contributions to understanding serotonin-mediated neuromodulation ๐ŸŽ“๐Ÿงช. Dr. Ciranna has also engaged in public science communication, appearing on RAI Telethon broadcasts ๐Ÿ“บ. Her work continues to shape novel approaches for treating cognitive disorders through serotonin receptor activation. ๐ŸŒ๐Ÿ“š

Research Focus

Assoc. Prof. Dr. Lucia Ciranna is dedicated to unraveling the complexities of the serotonin brain system ๐Ÿง , exploring its role in neurological disorders and potential therapeutic interventions. Her research focuses on Fragile X Syndrome ๐Ÿงฌ, aiming to develop targeted treatments for cognitive deficits. She investigates neurodevelopmental disorders ๐Ÿ’ก, shedding light on autism, intellectual disabilities, and brain dysfunctions. Her work also delves into glial-neuronal interactions ๐Ÿค, examining their impact on neurodevelopment and inflammation. Passionate about therapeutic innovations in neuroscience ๐Ÿฅ, she seeks novel drug targets and treatment strategies to improve neurological health and patient outcomes.

Publication Top Notesย 

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Amirsina Sharifi | Medicine and Health Sciences | Best Researcher Award

Dr Amirsina Sharifi, Cancer Institute, Iran

Dr. Amirsina Sharifi ๐Ÿฅ๐Ÿ”ฌ is a board-certified general surgeon specializing in trauma and surgical oncology. He earned his M.D. and completed his residency at Tehran University of Medical Sciences ๐ŸŽ“. With experience as a general surgeon at Shafa Hospital and Ziaeian Hospital, he actively contributes to surgical research at Sina Trauma and Surgery Research Center and the Cancer Institute Research Center. His expertise spans epidemiology, surgical interventions, and molecular biology ๐Ÿงฌ. A prolific researcher, he has numerous publications in high-impact journals. Ranked 7th in Iranโ€™s national entrance exam, he is a dedicated educator and a member of prestigious medical organizations ๐Ÿ†๐Ÿ“š.

Publication Profile

Google Scholar

Education

Dr. Amirsina Sharifi is a dedicated general surgeon ๐Ÿฅ with a strong academic background from Tehran University of Medical Sciences ๐ŸŽ“. He completed his medical school studies (2009 โ€“ 2015) and pursued an internship (2015 โ€“ 2017) at the same institution, gaining extensive hands-on experience. Dr. Sharifi then specialized in general surgery through a rigorous residency program (2018 โ€“ 2022) ๐Ÿ”ฌ. His expertise was solidified when he achieved board certification in general surgery in September 2022 ๐Ÿ†. With years of training and a passion for patient care, he continues to contribute to the medical field with skill and dedication ๐Ÿ’‰.

Experience

Dr. Amirsina Sharifi is a dedicated medical professional ๐Ÿฉบ with extensive experience in general surgery and research. He began his career as a General Practitioner at Shafa Hospital, Birjand University of Medical Sciences (July 2017 โ€“ August 2018) in South Khorasan, Iran. Later, he served as a General Surgeon at Shafa Hospital, Kurdestan University of Medical Sciences (October 2022 โ€“ March 2024) in Saqqez, Kurdestan, Iran. Since April 2024, he has been practicing at Ziaeian Hospital, Tehran University of Medical Sciences. Alongside his clinical work, he has been a Research Associate at Sina Trauma and Surgery Research Center (since May 2015) and the Cancer Institute Research Center (since August 2018) at Tehran University of Medical Sciences ๐Ÿ”ฌ๐Ÿ“š.

Workshops and Certificationsย 

Dr. Amirsina Sharifi has pursued extensive professional development through specialized workshops and certifications ๐ŸŽ“. He has successfully completed Advanced Trauma Life Support ๐Ÿš‘, Cardiopulmonary Resuscitation โค๏ธ, Research Methodology ๐Ÿ“Š, and Scientific Writing โœ๏ธ at Tehran University of Medical Sciences ๐Ÿฅ. These achievements reflect his dedication to both clinical excellence and academic research, enhancing his expertise in emergency care and scholarly contributions ๐Ÿ“–. His commitment to continuous learning ensures he stays at the forefront of medical advancements, equipping him with the skills to provide high-quality patient care while also contributing to the scientific community ๐Ÿ”ฌ.

Teaching and Mentorshipย 

Dr. Amirsina Sharifi is deeply committed to medical education, playing a vital role in shaping future healthcare professionals ๐Ÿ‘จโ€โš•๏ธ๐Ÿ“š. He conducts monthly surgical training sessions ๐Ÿฅโœ‚๏ธ, providing hands-on experience to aspiring surgeons. Additionally, he delivers weekly lectures on disease management, ensuring students gain comprehensive medical knowledge ๐Ÿง‘โ€โš•๏ธ๐Ÿ“–. His dedication to mentoring and guiding undergraduates reflects his passion for teaching and expertise in the field ๐ŸŽ“๐Ÿ’ก. Through his continuous efforts, Dr. Sharifi contributes significantly to the advancement of medical education and the development of skilled healthcare practitioners ๐Ÿ’‰๐Ÿ”ฌ.

Awards and Honorsย 

Dr. Amirsina Sharifi ๐ŸŽ“๐Ÿ… achieved an outstanding academic milestone by securing 7th place among 3.7 million candidates in Iranโ€™s national university entrance exam ๐Ÿ“šโœจ. As a distinguished member of Tehran University’s Exceptional Talent Development Center ๐ŸŽ–๏ธ, he has demonstrated excellence in academia and research. Dr. Sharifi is actively affiliated with the Iranian Association of Surgeons ๐Ÿฅ๐Ÿ”ฌ and the Iranian Medical Council โš•๏ธ, contributing to the advancement of medical sciences. His dedication to surgical excellence and professional development continues to shape his impactful career in the medical field ๐Ÿ†๐Ÿ‘จโ€โš•๏ธ.

Research Focus

Dr. Amirsina Sharifi’s research primarily focuses on public health, environmental medicine, and clinical surgery ๐Ÿฅ๐ŸŒ. His studies examine the health effects of air pollution ๐ŸŒซ๏ธ on disease risk, obesity treatments like laparoscopic gastric procedures โš•๏ธ, and the management of deep neck abscesses using ultrasound-guided techniques. Additionally, he has explored non-alcoholic fatty liver disease ๐Ÿ, emergency medicine approaches for acute abdominal pain ๐Ÿค•, and autism awareness among healthcare professionals ๐Ÿง . His work also includes home-based rehabilitation ๐Ÿก for spinal cord injuries, emphasizing patient-centered recovery. Overall, his research spans environmental health, surgery, and rehabilitation medicine for improved healthcare outcomes. โœ…

Publication Top Notes

The association between exposure to air pollutants including PM10, PM2. 5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration and the relative risk ofย โ€ฆ

Comparison of short-term effectiveness and postoperative complications: laparoscopic gastric plication vs laparoscopic sleeve gastrectomy

Is ultrasonography-guided drainage a safe and effective alternative to incision and drainage for deep neck space abscesses?

Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; prevalence and its association with metabolic disorders: a cross-sectional study

A preliminary survey of autism knowledge and attitude among health care workers and pediatricians in Tehran, Iran

Home-based rehabilitation programs: promising field to maximize function of patients with traumatic spinal cord injury